Is AcelRx Pharmaceuticals Inc (ACRX) a Winner in the Drug Manufacturers

Is AcelRx Pharmaceuticals Inc (ACRX) a Winner in the Drug Manufacturers - Specialty & Generic Industry?

Friday, December 30, 2022 03:28 PM | InvestorsObserver Analysts

Mentioned in this article

Is AcelRx Pharmaceuticals Inc (ACRX) a Winner in the Drug Manufacturers - Specialty & Generic Industry?

A rating of 88 puts AcelRx Pharmaceuticals Inc (ACRX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AcelRx Pharmaceuticals Inc's score of 88 means it scores higher than 88% of stocks in the industry. AcelRx Pharmaceuticals Inc also received an overall rating of 58, putting it above 58% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 144 out of the 148 industries.

ACRX has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on ACRX!

See Full ACRX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With AcelRx Pharmaceuticals Inc Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock has gained 7.98% while the S&P 500 is down -0.82% as of 3:25 PM on Friday, Dec 30. ACRX is up $0.17 from the previous closing price of $2.13 on volume of 122,828 shares. Over the past year the S&P 500 has fallen -20.11% while ACRX is down -76.55%. ACRX earned $6.21 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.37. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.